BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
See today's BioWorld
Home
» In the clinic for Oct. 26, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
In the clinic for Oct. 26, 2021
Oct. 26, 2021
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allergy Therapeutics, Anheart, Anixa, Applied Therapeutics, Aquestive, Astrazeneca, Beckley, Cantargia, Concert, Cybrexa, Cytodyn, Desentum, Dice, Erytech, Finch, Horizon, Innovent, Janssen, Kiromic, Mallinckrodt, Merck & Co., Moderna, Nanobiotix, Novartis, Olipass, Oncxerna, Phathom, Redhill, Regeneron, Sanofi, Turning Point, Vicore.
BioWorld
Briefs
Clinical
In the clinic
Coronavirus